Schizoaffective Disorders Completed Phase 4 Trials for Acamprosate (DB00659)

Also known as: Schizoaffective disorder / Schizophrenia schizoaffective / Schizoaffective psychosis / Schizo-affective type schizophrenia

IndicationStatusPhase
DBCOND0033299 (Schizoaffective Disorders)Completed4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00688324Biomarker Study of Acamprosate in SchizophreniaTreatment